Salarius Pharmaceuticals, Inc.

Clinical-stage biopharma developing targeted protein therapies for cancer and viral diseases.

SLRX | NDAQ

Overview

Corporate Details

ISIN(s):: US79400X4043 (+1 more)
LEI:
Country:: United States of America
Address:: 2450 HOLCOMBE BLVD, 77021 HOUSTON
Website:: https://salariuspharma.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for patients with cancer and other diseases with high unmet medical needs. The company's technology aims to correct the dysregulated gene expression that drives disease progression. Its pipeline is built on two primary drug classes: targeted protein inhibitors (TPIs) and targeted protein degraders (TPDs). The lead TPI candidate, seclidemstat (SP-2577), is in Phase 1/2 clinical trials for solid and hematologic cancers like leukemias and lymphomas. The company's TPD candidate, SP-3164, is in IND-enabling studies. Following a merger with Decoy Therapeutics, Salarius is also advancing peptide therapeutics for cancer and respiratory viruses.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Salarius Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Salarius Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Salarius Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
FRIENDLY CORPORATION Offers digital solutions for business growth: web production, marketing, e-commerce, & incubation.	Japan	8209
FTAI Infrastructure Inc. Develops, acquires, and operates critical infrastructure in rail, ports, power, and gas.	United States of America	FIP
FunPep Company Limited Biotech firm developing peptide-based therapeutics, cosmetics, and medical devices.	Japan	4881
Gain Therapeutics, Inc. Using an AI platform to develop allosteric therapies for neurodegenerative diseases.	United States of America	GANX
GALAPAGOS NV Developing a rapid, decentralized cell therapy platform for oncology and immunology.	United States of America	GLPG
Galaxy Payroll Group Ltd APAC cross-border payroll, EOR, and corporate services for global businesses.	United States of America	GLXG
GATX CORP Global lessor of railcars, locomotives, and spare aircraft engines for key industries.	United States of America	GATX
GECOSS CORPORATION Leases and sells temporary steel materials and equipment for large construction projects.	Japan	9991
GENDAI AGENCY INC. Advertising agency providing marketing and promotions for the pachinko industry.	Japan	2411
Geneuro Developing antibody therapies targeting pathogenic HERVs for MS and post-COVID syndromes.	Switzerland	GEM